Immunohistochemical expression of COX-2, Ki-67, Bcl-2, Bax, VEGF and CD105 according to histological grading in oral squamous cell carcinoma
- 1 June 2023
- journal article
- research article
- Published by Elsevier in Revista Española de Patología
- Vol. 56 (3) , 147-157
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Expression and clinical implication of cyclooxygenase-2 and E-cadherin in oral squamous cell carcinomasCancer Biology & Therapy, 2020
- The prognostic value of immunohistochemical markers for oral tongue squamous cell carcinomaEuropean Archives of Oto-Rhino-Laryngology, 2014
- Inflammation in the context of oral cancerOral Oncology, 2013
- CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34Virchows Archiv, 2013
- Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical StudiesClinical Cancer Research, 2013
- Expression of vascular endothelial growth factor and microvessel density in oral tumorigenesisJournal of Oral and Maxillofacial Pathology, 2012
- Malignancy grading is no better than conventional histopathological grading in small squamous cell carcinoma of tongue and floor of mouth: retrospective study in 128 patientsJournal of Oral Pathology & Medicine, 2009
- Prognostic significance of Bcl‐2 and Bax protein expression in the patients with oral squamous cell carcinomaJournal of Oral Pathology & Medicine, 2009
- A study of phosphorylated ERK1/2 and COX‐2 in early stage (T1–T2) oral squamous cell carcinomasJournal of Oral Pathology & Medicine, 2008
- Loss of BCL-2 in the progression of oral cancer is not attributable to mutationsJournal of Clinical Pathology, 2005